HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium.
about
Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1The Landscape of Pancreatic Cancer Therapeutic Resistance MechanismsCurrent Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and TreatmentMultiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosisDevelopment of a novel DNA aptamer ligand targeting to primary cultured tumor endothelial cells by a cell-based SELEX methodFolate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migrationTumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis.The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinomaThe mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.Suppression of laser-induced choroidal neovascularization by intravitreal injection of tristetraprolin.Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironmentSuprabasin as a novel tumor endothelial cell marker.Identification and expression of troponin T, a new marker on the surface of cultured tumor endothelial cells by aptamer ligand.Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype.Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function.The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis.TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells.Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.Altered angiogenesis in the tumor microenvironment.Heterogeneity of tumor endothelial cells.Post-transcriptional gene regulation by RNA-binding proteins in vascular endothelial dysfunction.Tumor angiogenesis--characteristics of tumor endothelial cells.CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective?Dysregulation of TTP and HuR plays an important role in cancers.Central Role of Metabolism in Endothelial Cell Function and Vascular Disease.The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma.CXCR7: a novel tumor endothelial marker in renal cell carcinoma.Isolation and genome-wide expression and methylation characterization of CD31+ cells from normal and malignant human prostate tissue.Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner.Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.Low expression of microRNA-143 is related to degenerative scoliosis possibly by regulation of cyclooxygenase-2 expression.Endothelial Cell Metabolism.Contribution of Tumor Endothelial Cells in Cancer Progression.Clinical Significance and Biological Role of HuR in Head and Neck Carcinomas.The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism
P2860
Q24626214-DE8C0A00-C218-4B1C-8EB9-BE7F98E6EB9DQ26765247-63145FBB-157E-406C-9258-4277441F3638Q28075325-DAC63C4D-E9BE-4D61-AAAB-EA1923CFCE4FQ28290458-770A19F2-7336-44EE-9D8E-ECF0E42807DAQ28485460-FB81665C-C4E2-4C4B-8FD1-36707D28840FQ28829561-4D8AB7DD-0BCE-4182-B06A-A6F35C8FDF29Q34222002-9CDB10FA-72F2-4A6F-B683-A18353D5EB5BQ34482531-EC3442C2-2737-4091-A5BF-40510C0590C0Q34494886-1E61D6AB-ABC3-429B-BF48-10FF283AC6BAQ34735778-BF1CCB0E-E4B7-4951-B523-0AE68A0FBC3DQ35048958-01C6FADF-2163-420D-944B-03FA365982EBQ35052030-C738FD30-9E94-4629-8B25-38CE8E438ECEQ35165550-214EA024-4E31-4797-A614-7E83D833F571Q35463822-C6EFCCD8-BE74-455F-A68D-807781DF9D80Q36265691-F303F4E9-43FA-4148-BA3B-503274CFD111Q36588945-F4CB070C-B2F4-4938-BBDF-3E03F14AE8F9Q36997307-89417269-E5EC-4BBF-A45A-29587913A2D6Q37235503-54C9354D-D861-4063-8B64-520552BA0D6FQ37357373-4593D674-59BC-493A-8B4D-F2F8894A0CBDQ37687521-D07FC081-A9C2-4D83-8671-B1F8D1E2A19EQ37949667-F8E7CF5F-4E89-461C-B2D0-254DD09CCD39Q38127709-33D83B34-008C-4B03-AF8C-6B6CC7DFBABCQ38238033-EFC64BFB-134C-477C-B54C-3528822ECBF7Q38734664-A1A8CF48-3BD8-4B92-8927-1C8852ADFA27Q38861083-001EF23F-C7C5-4039-A3BD-1D110AB6976AQ38882106-541ABD72-8974-4FBD-969E-523493D55036Q38958552-A360B69D-856F-4130-A740-7B5ECD4D6B52Q39137289-26D1A16A-6134-4D5B-9B61-AB1DEDF50BECQ39203504-8F4B4AC9-CB56-4C51-9365-31725B164792Q39360771-31AB225E-1A7F-4252-B425-B15D8334D7C9Q39361103-1A47E5C4-8D4B-4EB2-ABAA-96E5FEAD7AD8Q39387572-850C9041-BDE1-4D2E-AF4A-80BC05353EC9Q39388535-680AEFC8-D162-4A16-9940-AB3901C03CD7Q40064209-E919F897-A659-4AE8-988F-E9013C648923Q41046953-6C59D03B-3801-4DDB-AF5C-F7F1A12630F6Q49787990-DF8A58BA-3968-46C9-9696-E83EB9CF287DQ52563257-21B21CD5-58FC-45DB-AB6A-24AD571D9581Q52606072-5D57052D-B205-4B3B-99F5-1F675FFD3E02Q57071744-79E2B6F0-4AD5-41A2-86D0-174279283779
P2860
HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
HuR keeps an angiogenic switch ...... d COX-2 in tumour endothelium.
@en
HuR keeps an angiogenic switch ...... d COX-2 in tumour endothelium.
@nl
type
label
HuR keeps an angiogenic switch ...... d COX-2 in tumour endothelium.
@en
HuR keeps an angiogenic switch ...... d COX-2 in tumour endothelium.
@nl
prefLabel
HuR keeps an angiogenic switch ...... d COX-2 in tumour endothelium.
@en
HuR keeps an angiogenic switch ...... d COX-2 in tumour endothelium.
@nl
P2093
P2860
P356
P1476
HuR keeps an angiogenic switch ...... d COX-2 in tumour endothelium.
@en
P2093
F Higashino
T Kuroshima
P2860
P2888
P304
P356
10.1038/BJC.2011.20
P407
P577
2011-02-01T00:00:00Z
P5875
P6179
1003884295